Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Study finds prebiotic fiber helps girls build more bone (opens in a new tab)

medicalxpress.com · 2026-10-15

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of four claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 2 supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredThe article says the MetA-Bone clinical trial was published in The American Journal of Clinical Nutrition.View evidenceHide evidence

Why this verdict

The supplied paper profile gives the document identifier and abstract-derived scientific content but does not include the journal citation field needed to verify that the trial was published in The American Journal of Clinical Nutrition.

Claim 2 of 4Not coveredThe researchers cautioned that the study was not designed to detect differences between boys and girls, so the finding needs confirmation in larger trials.View evidenceHide evidence

Why this verdict

The profile does show sex-stratified analyses and baseline sex differences that motivated stratification, and it lists sex-specific effect uncertainty as a limitation. However, the supplied abstract-level profile does not state that the study was not designed or powered to detect sex differences, nor does it state that larger trials are needed for confirmation. This caveat may be true from full text or researcher comments, but it is not verifiable from the provided abstract-depth evidence.

1

Study evidence

In girls, 1-year gain in whole-body BMC was greater with SCF than with placebo after adjustment for growth and body-composition covariates.SCF: 216.3 ± 138.3 g (18.8%) vs placebo: 139.9 ± 84.0 g (12.9%); P < 0.05

“Healthy children and adolescents (9-14 y old) with usual low calcium intake were recruited and randomly assigned for 1 y to SCF (12 g/d) or placebo”
2

Study evidence

Girls had higher maturational status and body fat than boys at baseline, and the authors stratified subsequent analyses by sex.Mean Tanner stage: girls 3.10 ± 1.20 vs boys 2.30 ± 1.20 (P < 0.001); body fat percentage higher in girls (P < 0.05).

“Most were White (41.3%), Hispanic (69.5%), and with healthy weight (74.0%).”
Claim 3 of 4SupportedGirls who added a prebiotic fiber supplement to their usual diets for a year built more bone than girls who took a placebo, according to a clinical trial led by Florida International University nutrition researcher Cristina Palacios.View evidenceHide evidence

Why this verdict

The paper profile supports the main scientific claim: this was a randomized 1-year SCF-versus-placebo trial in 9–14-year-olds, and girls receiving SCF had greater gains in whole-body bone measures than girls receiving placebo. Because the evidence is interventional, the story’s causal wording is not an observational-overreach problem. The supplied abstract-level profile does not independently verify the FIU/Palacios leadership detail, but it does support the trial finding that is central to the claim.

1

Study evidence

In girls, 1-year gain in whole-body BMC was greater with SCF than with placebo after adjustment for growth and body-composition covariates.SCF: 216.3 ± 138.3 g (18.8%) vs placebo: 139.9 ± 84.0 g (12.9%); P < 0.05

“Healthy children and adolescents (9-14 y old) with usual low calcium intake were recruited and randomly assigned for 1 y to SCF (12 g/d) or placebo”
Claim 4 of 4SupportedOver 12 months, bone mineral content in girls who took soluble corn fiber increased by 18.8%, compared with 12.9% in the placebo group; the same effect was not seen in boys.View evidenceHide evidence

As stated18.8% vs 12.9%

Why this verdict

The stated BMC percentages match the profile: girls receiving SCF gained 216.3 ± 138.3 g, reported as 18.8%, versus 139.9 ± 84.0 g, reported as 12.9%, in placebo after adjustment. The profile also says no SCF-related increase in BMC/BMD was observed in boys.

1

Study evidence

In girls, 1-year gain in whole-body BMC was greater with SCF than with placebo after adjustment for growth and body-composition covariates.SCF: 216.3 ± 138.3 g (18.8%) vs placebo: 139.9 ± 84.0 g (12.9%); P < 0.05

“Healthy children and adolescents (9-14 y old) with usual low calcium intake were recruited and randomly assigned for 1 y to SCF (12 g/d) or placebo”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The trial population was healthy children/adolescents aged 9–14 with low habitual calcium intake.

    The story says girls and boys added the supplement to their usual diets, but it does not convey the age range or the low-calcium-intake eligibility criterion, both of which affect generalizability.

    From Randomized clinical trial (factorial with calcium supplementation)

  • The study included a factorial calcium-supplementation component, and the SCF benefit was not observed when calcium supplementation was added.

    This secondary but interpretation-relevant paper element is absent from the story presentation. It matters because the apparent SCF benefit depended on whether calcium was co-administered.

    From Factorial randomized controlled trial component

  • The girls’ result was based on adjusted analyses accounting for age, Tanner stage, growth/body-composition velocities, and compliance.

    The story gives the percentage comparison but does not describe the covariate-adjusted nature of the analysis, which is relevant because growth and pubertal development are central to bone outcomes in this age range.

    From Randomized clinical trial (factorial with calcium supplementation)

  • The authors stratified by sex because girls and boys differed at baseline in Tanner stage and body fat percentage.

    The story mentions a caution about sex-difference detection, but it does not reflect the paper-profile element that baseline maturational and body-composition differences motivated the sex-stratified reporting.

    From baseline descriptive comparisons

3 things the story did carry across
  • The study was a randomized 1-year human clinical trial of soluble corn fiber versus placebo, with DXA-measured bone mineral content and density outcomes.
  • In girls, whole-body BMC gain over 1 year was greater with SCF than placebo, with the reported 18.8% versus 12.9% figures; no comparable SCF benefit was observed in boys.
  • The paper also reports a similar sex-specific pattern for whole-body BMD, not only BMC.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoDetermine whether 1-year soluble corn fiber (SCF) supplementation increases bone mass (BMC/BMD) compared with placebo in children/adolescents with low habitual calcium intake.Randomized clinical trial (factorial with calcium supplementation)Expand

In plain English

Randomized clinical trial in 9–14-year-old children with low habitual calcium intake comparing 1 year of soluble corn fiber (SCF, 12 g/d) versus placebo (maltodextrin) with a factorial calcium supplementation (600 mg/d) arm; whole-body BMC and BMD measured by DXA at baseline, 6 mo, and 12 mo. Among trial completers, girls receiving SCF had larger 1‑year increases in whole-body BMC and BMD than girls receiving placebo after multivariable adjustment; no benefit was observed in boys or when calcium supplementation was added.

Key findings

  • In girls, 1-year gain in whole-body BMC was greater with SCF than with placebo after adjustment for growth and body-composition covariates.SCF: 216.3 ± 138.3 g (18.8%) vs placebo: 139.9 ± 84.0 g (12.9%); P < 0.05
  • Whole-body BMD showed similar sex-specific patterns: girls on SCF had greater 1-year increases than girls on placebo.
“Healthy children and adolescents (9-14 y old) with usual low calcium intake were recruited and randomly assigned for 1 y to SCF (12 g/d) or placebo”
What this piece can’t prove
  • Results in abstract are reported for completers (n = 151); retention and intention-to-treat details not provided in abstract.
  • Sex-specific effect: benefit limited to girls; mechanisms and generalizability to boys unclear from abstract.
  • Calcium factorial interaction: SCF benefit was not observed when calcium supplementation was added, but detailed interaction statistics are not reported in abstract.
  • Demographic composition (majority White and Hispanic; majority healthy weight) may limit generalizability to other populations.
  • Abstract does not report blinding, adherence rates beyond 'compliance' adjustment, or detailed randomization procedures.
2human in vivoAssess whether adding calcium supplementation (calcium gluconate) modifies the effect of SCF on bone outcomes (factorial comparison: with vs without calcium).Factorial randomized controlled trial componentExpand

In plain English

In the MetA-Bone 1-year randomized trial with a factorial component (SCF 12 g/d vs placebo, crossed with calcium gluconate 600 mg/d vs no calcium), the abstract reports that the beneficial effect of soluble corn fiber (SCF) on whole-body bone mineral content (BMC) and bone mineral density (BMD) observed in girls was not seen when calcium supplementation was co-administered. Analyses used DXA at baseline, 6 and 12 months and linear mixed-effects/ANOVA with adjustment for multiple growth- and body-composition covariates.

Key findings

  • The abstract reports that the SCF-associated increases in whole-body BMC and BMD observed in girls were not observed when calcium gluconate (600 mg/d) was co-supplemented.
“randomly assigned for 1 y to SCF (12 g/d) or placebo (12 mg/d), with or without calcium (600 mg/d).”
What this piece can’t prove
  • Calcium effect reported as secondary; full trial report may be needed for prespecified interaction testing and power for factorial comparisons.
  • Available summary is limited to abstract information (no full-text details on adherence by arm, exact subgroup sample sizes, or formal interaction testing provided).

2 further details could not be confirmed from the summary.

3human in vivoDescribe/characterize participant baseline features and sex differences (e.g., Tanner stage, body fat) that motivate sex-stratified analyses.baseline descriptive comparisonsExpand

In plain English

Baseline participant characteristics are reported for the trial cohort and show sex differences in maturational status and body composition: girls had higher Tanner stage and higher body fat percentage than boys, which the authors state prompted sex-stratified analyses. Demographics and sample sizes are reported in the abstract.

Key findings

  • Girls had higher maturational status and body fat than boys at baseline, and the authors stratified subsequent analyses by sex.Mean Tanner stage: girls 3.10 ± 1.20 vs boys 2.30 ± 1.20 (P < 0.001); body fat percentage higher in girls (P < 0.05).
“Most were White (41.3%), Hispanic (69.5%), and with healthy weight (74.0%).”
What this piece can’t prove

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 30 candidate papers

And 24 more candidates considered.